Rini, Brian I <br/><br/>
A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.  [electronic resource] 

 -  The Journal of urology  Aug 2015 
 - 297-303 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1527-3792 
<br/><br/><label>Standard No.: </label>10.1016/j.juro.2015.03.096  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Carcinoma, Renal Cell--diagnosis<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate--drug effects<br/>Humans<br/>Indazoles<br/>Kidney--diagnostic imaging<br/>Kidney Neoplasms--diagnosis<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Nephrectomy--methods<br/>Organ Size<br/>Prospective Studies<br/>Pyrimidines--administration & dosage<br/>Retrospective Studies<br/>Sulfonamides--administration & dosage<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Tumor Burden